← back to search

Gajanan D. Katkar

University of California San Diego · US
Area of research
Genetics · Immunology
Research interest
Research interests include Immune cells in cancer, Inflammatory Bowel Disease, Venomous Animal Envenomation and Studies, and Single-cell and spatial transcriptomics.
h-index
18
citations
1,153
works
50
NIH funding
primary concept
email

Recent publications

A living organoid biobank of patients with Crohn’s disease reveals molecular subtypes for personalized therapeutics
Cell Reports Medicine 2024cited by 21position: middledoi
Macrophage states: there's a method in the madness
Trends in Immunology 2023cited by 39position: firstdoi
Machine learning identifies signatures of macrophage reactivity and tolerance that predict disease outcomes
EBioMedicine 2023cited by 35position: middledoi
An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease
Nature Communications 2022cited by 82position: middledoi
COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis
EBioMedicine 2022cited by 42position: middledoi
Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19
eLife 2021cited by 133position: middledoi
Parsing the Role of PPARs in Macrophage Processes
Frontiers in Immunology 2021cited by 102position: lastdoi
Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease
Nature Communications 2021cited by 81position: middledoi
AI-guided discovery of the invariant host response to viral pandemics
EBioMedicine 2021cited by 54position: middledoi
Chromogranin A regulates gut permeability <i>via</i> the antagonistic actions of its proteolytic peptides
Acta Physiologica 2021cited by 35position: middledoi
TLR4 signaling and macrophage inflammatory responses are dampened by GIV/Girdin
Proceedings of the National Academy of Sciences 2020cited by 104position: middledoi
Host engulfment pathway controls inflammation in inflammatory bowel disease
FEBS Journal 2020cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Pradipta Ghosh · UC San Diego Health System12 papers (2020–2024)Soumita Das · University of Massachusetts Lowell10 papers (2020–2024)Debashis Sahoo · University of California San Diego7 papers (2021–2024)Courtney Tindle · University of California San Diego5 papers (2021–2024)Stella‐Rita Ibeawuchi · University of San Diego4 papers (2020–2024)Sahar Taheri · Shiraz University4 papers (2021–2024)Vanessa Castillo · University of California San Diego4 papers (2020–2022)Mackenzie Fuller · Rocky Mountain MS Center4 papers (2021–2024)Ayden G. Fonseca · University of California San Diego3 papers (2021–2024)Rama F. Pranadinata · University of California San Diego3 papers (2020–2024)Ibrahim M. Sayed · System Biosciences (United States)3 papers (2020–2024)William J. Sandborn · Mirati Therapeutics (United States)3 papers (2020–2024)Jason M. Duran · Ionis Pharmaceuticals (United States)2 papers (2021–2021)Nathan Beutler · Scripps Research Institute2 papers (2021–2021)Dominik L. Stec · University of California San Diego2 papers (2021–2024)Jennifer M. Dan · University of California System2 papers (2021–2022)Mahitha Shree Anandachar · University of California San Diego2 papers (2020–2024)Laura E. Crotty Alexander · University of Nebraska at Omaha2 papers (2021–2021)Amanraj Claire · University of California San Diego2 papers (2021–2021)Ranajoy Chattopadhyay · Research Applications (United States)2 papers (2020–2021)